Share Buyback Transaction Details December 15 - 21, 2016
December 22, 2016 - Wolters Kluwer today reported that it has repurchased 238,450 of its own ordinary shares in the period from December 15, 2016 through December 21, 2016 for €8.1 million in total and at an average share price of €33.92.
These share repurchases are part of the three-year (2016-2018), up to €600 million buyback program announced on February 24, 2016. The total number of shares repurchased under the €600 million buyback program to date is 5.5 million shares for a total consideration of €189 million.
Wolters Kluwer has committed itself to the repurchase of ordinary shares for a maximum total consideration of €95 million in the period November 3, 2016 up to and including December 30, 2016, for capital reduction purposes or to meet obligations arising from share based incentive plans, within the limits of relevant laws and regulations and Wolters Kluwer's Articles of Association.
Further detailed information is available:
- Download the share buyback transactions excel sheet for detailed individual transaction information.
- Weekly reports on the progress of our share repurchases.
- Overview of share buyback programs.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in professional information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
|Annemarije Pikaar||Meg Geldens|
|Corporate Communications||Investor Relations|
|t + 31 172 641 470||t + 31 172 641 407|
Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall" and similar expressions. Wolters Kluwer cautions that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This press release contains information which is to be made publicly available under Regulation (EU) 596/2014.
Source:Wolters Kluwer NV